Scientists closer to drug that cuts nicotine dependence

 
Related

Eye-catching NuBike goes with drive levers instead of a chain

Health at home
658 points

How to tell if cheat days are sabotaging your weight loss

Health at home
338 points



Most recent

GrupoCnet: nuevo grupo empresarial del Valle del Cauca

Luisa Fernanda Rozo
16 points

Murió Pablo Milanés, con él se va parte de nuestra propia vida. DEP

El diario de Enrique
16 points

Tengo algo muy importante que hacer

El diario de Enrique
12 points

Quizás sea algo urgente: Enseña a tus hijos a ser humildes y educados

NOTICIAS-ETF
120 points

Ahora que calienta el corazón

El diario de Enrique
12 points

La realidad no tiene estilo ni talento.

El diario de Enrique
8 points

No lo es: El Mundial de Qatar se ha presentado como el más sostenible de la historia

NOTICIAS-ETF
16 points

MISEVI BARQUISIMETO

MISEVI VENEZUELA.
52 points

Ahora veteranos ya le dimos alcance a la verdad

El diario de Enrique
6 points

Dynatrace amplía Grail para potenciar la Analítica Empresarial

Tecnologia
26 points
SHARE
TWEET
Researchers say they've created an enzyme that might one day reduce nicotine cravings in smokers.

Scientists closer to drug that cuts nicotine dependence

The scientists gave the enzyme to nicotine-dependent rats and found it broke down nicotine in the bloodstream before it could reach the brain.

This quickly reduced the rats' nicotine dependence. It also prevented them from relapsing when they again had access to nicotine, according to the study.

"This is a very exciting approach because it can reduce nicotine dependence without inducing cravings and other severe withdrawal symptoms," said principal investigator Olivier George. He's an associate professor at Scripps Research Institute in La Jolla, California.

U.S. FDA cracks down on electronic cigarette producers

The U.S. Food and Drug Administration sent letters to 21 electronic cigarette manufacturers seeking information to assess whether the products are being marketed illegally.

Also, the enzyme "works in the bloodstream, not the brain, so its side-effects should be minimal," George added in an institute news release.

Nicotine dependence is what makes it so difficult for people to quit smoking. Preventing the nicotine in tobacco from reaching the brain has long been seen as a promising way of reducing dependence, but previous efforts haven't resulted in drugs that reduce blood levels of nicotine enough to be effective.

The enzyme tested in this study is called NicA2-J1. It's based on a natural enzyme produced by the bacterium Pseudomonas putida, but was modified to boost its potency, staying time in the blood, and other features to fight nicotine dependence.

The researchers plan to continue to improve the enzyme's properties with the goal of eventually conducting human clinical trials. However, it's important to note that results of animal trials aren't always replicable in humans.

The findings were published online Octber 17 in Science Advances.

Fuente: www.health24.com
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content